BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Characterization of mannanase from Bacillus circulans NT 6.7 and its application in mannooligosaccharides preparation as prebiotic. ✅
Go to Publication ✅
SpringerPlus (Springerplus ) Vol: 4 Issue Pages: 771 Pub: 2015 Epub: 2015 Dec 14 Authors Pangsri P , Piwpankaew Y , Ingkakul A , Nitisinprasert S , Keawsompong S , |
|
|
Antibacterial activity of konjac glucomannan/chitosan blend films and their irradiation-modified counterparts. ✅
Go to Publication ✅
Carbohydrate polymers (Carbohydr Polym ) Vol: 92 Issue 2 Pages: 1302-7 Pub: 2013 Feb 15 Epub: 2012 Oct 12 Authors Du X , Yang L , Ye X , Li B , |
|
|
Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota. ✅
Go to Publication ✅
International journal of obesity (2005) (Int J Obes (Lond) ) Vol: Issue Pages: Pub: 2018 Sep 21 Epub: 2018 Sep 21 Authors Kang Y , Li Y , Du Y , Guo L , Chen M , Huang X , Yang F , Hong J , Kong X , |
|
|
Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota. ✅
Go to Publication ✅
International journal of obesity (2005) (Int J Obes (Lond) ) Vol: Issue Pages: Pub: 2018 Sep 21 Epub: 2018 Sep 21 Authors Kang Y , Li Y , Du Y , Guo L , Chen M , Huang X , Yang F , Hong J , Kong X , |
|
|
Targeted modification of gut microbiota and related metabolites via dietary fiber. ✅
Go to Publication ✅
Carbohydrate polymers (Carbohydr Polym ) Vol: 316 Issue Pages: 120986 Pub: 2023 Sep 15 Epub: 2023 May 16 Authors Nie Q , Sun Y , Li M , Zuo S , Chen C , Lin Q , Nie S , |
|
|
Manno-oligosaccharides from Cassia Seed Gum Attenuate Atherosclerosis through Inflammation Modulation and Intestinal Barrier Integrity Improvement in ApoE(-/-) Mice. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: Issue Pages: e2300187 Pub: 2023 Nov 15 Epub: 2023 Nov 15 Authors Li J , Zhen H , Yang S , Yan Q , Jiang Z , |
|
|
Effects of Konjaku Flour on the Gut Microbiota of Obese Patients. ✅
Go to Publication ✅
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 12 Issue Pages: 771748 Pub: 2022 Epub: 2022 Mar 1 Authors Li Y , Kang Y , Du Y , Chen M , Guo L , Huang X , Li T , Chen S , Yang F , Yu F , Hong J , Kong X , |
|
|
Effects of Konjaku Flour on the Gut Microbiota of Obese Patients. ✅
Go to Publication ✅
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 12 Issue Pages: 771748 Pub: 2022 Epub: 2022 Mar 1 Authors Li Y , Kang Y , Du Y , Chen M , Guo L , Huang X , Li T , Chen S , Yang F , Yu F , Hong J , Kong X , |
|
|
Amelioration of gut dysbiosis and gastrointestinal motility by konjac oligo-glucomannan on loperamide-induced constipation in mice. ✅
Go to Publication ✅
Nutrition (Burbank, Los Angeles County, Calif.) (Nutrition ) Vol: 73 Issue Pages: 110715 Pub: 2020 May Epub: 2019 Dec 23 Authors Hayeeawaema F , Wichienchot S , Khuituan P , |
|
|
Novel ß-mannanase/GLP-1 fusion peptide high effectively ameliorates obesity in a mouse model by modifying balance of gut microbiota. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 191 Issue Pages: 753-763 Pub: 2021 Nov 30 Epub: 2021 Sep 28 Authors Wang Y , Ablimit N , Zhang Y , Li J , Wang X , Liu J , Miao T , Wu L , Wang H , Wang Z , Lou H , Jiang W , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
